Lexicon Pharmaceuticals Stock (NASDAQ: LXRX) stock price, news, charts, stock research, profile.
Open | $1.790 |
Close | - |
Volume / Avg. | 184.660K / 4.497M |
Day Range | 1.760 - 1.815 |
52 Wk Range | 0.920 - 3.730 |
Market Cap | $443.226M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 42.17% |
Days to Cover | 9.13 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ: LXRX) through any online brokerage.
Other companies in Lexicon Pharmaceuticals’s space includes: Voyager Therapeutics (NASDAQ:VYGR), PepGen (NASDAQ:PEPG), Replimune Group (NASDAQ:REPL), Fate Therapeutics (NASDAQ:FATE) and Anika Therapeutics (NASDAQ:ANIK).
The latest price target for Lexicon Pharmaceuticals (NASDAQ: LXRX) was reported by Needham on Friday, May 3, 2024. The analyst firm set a price target for 0.00 expecting LXRX to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $1.8 last updated Today at May 9, 2024 at 10:40 AM EDT.
There are no upcoming dividends for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.